| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,238 |
8,273 |
$844K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,354 |
1,278 |
$650K |
| 96112 |
|
3,215 |
2,288 |
$330K |
| S0281 |
Medical home program, comprehensive care coordination and planning, maintenance of plan |
44,336 |
43,910 |
$242K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,484 |
5,129 |
$215K |
| 87631 |
|
1,476 |
1,407 |
$209K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,987 |
2,785 |
$197K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,482 |
2,172 |
$152K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,511 |
1,410 |
$120K |
| 87581 |
|
2,964 |
2,785 |
$112K |
| 87486 |
|
2,971 |
2,781 |
$112K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,109 |
1,039 |
$81K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
978 |
956 |
$80K |
| 99490 |
Ccm add 20min |
1,850 |
1,845 |
$69K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,974 |
2,864 |
$61K |
| 99188 |
|
1,873 |
1,785 |
$58K |
| 99070 |
|
6,871 |
5,903 |
$58K |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
2,065 |
1,886 |
$56K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,291 |
1,233 |
$50K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,398 |
1,340 |
$48K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,819 |
1,509 |
$47K |
| E0570 |
Nebulizer, with compressor |
5,380 |
5,319 |
$39K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
329 |
314 |
$34K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,017 |
1,863 |
$27K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,457 |
1,266 |
$25K |
| 87807 |
|
1,482 |
1,425 |
$20K |
| 87634 |
|
178 |
172 |
$11K |
| 99215 |
Prolong outpt/office vis |
58 |
56 |
$7K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
76 |
76 |
$7K |
| 36416 |
|
2,015 |
1,693 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
361 |
346 |
$5K |
| A7015 |
Aerosol mask, used with dme nebulizer |
2,059 |
1,908 |
$4K |
| 83655 |
|
214 |
211 |
$3K |
| 99000 |
|
700 |
563 |
$3K |
| 82947 |
|
192 |
180 |
$3K |
| 80061 |
Lipid panel |
173 |
161 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
12 |
12 |
$2K |
| 99401 |
|
50 |
42 |
$1K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
1,634 |
1,550 |
$1K |
| G9920 |
Screening performed and negative |
155 |
148 |
$899.00 |
| 85018 |
|
415 |
379 |
$723.86 |
| 90670 |
|
910 |
827 |
$715.18 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
12 |
$533.40 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
1,843 |
1,751 |
$507.50 |
| 90686 |
|
2,116 |
2,087 |
$493.83 |
| 90680 |
|
364 |
363 |
$243.84 |
| 90651 |
|
183 |
178 |
$239.29 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
1,793 |
1,668 |
$204.77 |
| G9919 |
Screening performed and positive and provision of recommendations |
12 |
12 |
$203.00 |
| 90723 |
|
424 |
413 |
$145.46 |
| 90648 |
|
834 |
741 |
$109.30 |
| 90633 |
|
347 |
320 |
$0.00 |
| 90461 |
|
1,453 |
1,213 |
$0.00 |
| 90707 |
|
238 |
169 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
50 |
45 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
413 |
329 |
$0.00 |
| 90685 |
|
15 |
15 |
$0.00 |
| 90658 |
|
99 |
99 |
$0.00 |
| 90700 |
|
18 |
14 |
$0.00 |
| 96161 |
|
82 |
81 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
322 |
298 |
$0.00 |
| 90716 |
|
249 |
173 |
$0.00 |
| A9270 |
Non-covered item or service |
54 |
43 |
$0.00 |
| 90698 |
|
65 |
65 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
47 |
39 |
$0.00 |
| J7131 |
Hypertonic saline solution, 1 ml |
30 |
30 |
$0.00 |
| 90744 |
|
29 |
29 |
$0.00 |